Abbott Laboratories (NYSE:ABT) reported on Friday that its board of directors authorised a common stock dividend of USD0.45 per share for the quarter, the company .
This 389th consecutive quarterly dividend will be paid on 17 May 2021 to shareholders of record at the close of business on 15 April 2021.
Also, the company said it has paid dividends since 1924 and increased its dividend payout for 49 consecutive years.
Abbott discovers, develops, manufactures and sells health care products worldwide. It operates through the Established Pharmaceutical Products segment; Diagnostic Products segment; and Medical Devices segment. It has an agreement with Tandem Diabetes Care to develop and commercialise integrated diabetes solutions.
The company was founded in 1888 and is headquartered in North Chicago, Illinois, USA.
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline